We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The new MHRA Safety Roundup provides a monthly summary of the latest safety advice for all medicines, medical devices, and healthcare products regulated by the MHRA, as part of our 3-year strategy to improve safety communica…
People who have purchased Boots Paracetamol 500mg Tablets 16s (Item code 81-99-922, Batch 241005, Expiry date 12/2029) are advised to stop using the product immediately and return it to a Boots store for a full refund, becau…
A review by 2 specialists will remain in place for patients starting valproate under 55 years of age.
The MHRA’s Criminal Enforcement Unit works to identify and prevent the illegal sale of weight-loss medicines online.
From coughs and sneezes to mental health apps, these tips from the MHRA will help you stay safe during the festive season and beyond
The ninth annual #MedSafetyWeek takes place this week, with regulators from 94 countries and 107 organisations taking part across the globe.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched its ambitious new business plan for 2024/25, setting out the agency’s core focus of enabling access to innovative healthcare products while en…
New strategy aims to transform the way we provide information on the risks and safety of medicines and medical devices.
Men taking valproate and their partners are being advised by the Medicines and Healthcare products Regulatory Agency (MHRA) to use effective contraception because of new data suggesting a potential small increased risk of ha…
Key advice on medicines and medical devices for the holiday season.
Migraine and antiseizure medication topiramate must no longer be prescribed to women and girls unless they fulfil the requirements of a Pregnancy Prevention Programme.
Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions
The MHRA will introduce a patient alert card to increase awareness among men taking finasteride about potential psychiatric and sexual side effects
DASA seeks innovations to provide protection for land based assets from air attacks
First published during the 2022 to 2024 Sunak Conservative government
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
The MHRA has reviewed the latest evidence relating to the very rare risk of PRES and RCVS associated with medicines containing pseudoephedrine
The Yellow Card Biobank will today start investigating a new group of medicines known as Direct Oral Anticoagulants
No one should stop taking valproate without advice from their healthcare professional
Do not stop your hypertriglyceridemia treatment without a discussion with your doctor
Following a review of the effectiveness of current measures to reduce the risk of potentially long-term or irreversible side effects associated with fluoroquinolone antibiotics, the MHRA has introduced further restrictions t…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).